tubercuslosis program (B&C Biopharm/Reyon Pharma/Wayne State University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametubercuslosis program (B&C Biopharm/Reyon Pharma/Wayne State University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesB&C Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesB&C PharmaWayne State UniversityReyon Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A